$CICB

CION Investment Corp (CICB): Results of Operations and Financial Condition

CION Investment Corp (CICB) filed an SEC Form 8-K — Results of Operations and Financial Condition. false 0001534254 CION Investment Corp 0001534254 2026-07-01 2026-07-01 0001534254 us-gaap:CommonStockMember 2026-07-01 2026-07-01 0001534254 cion:SevenandhalfpercentNotesdue2029Member 2026-07-01 2026-07-01 0001534254 cion:SevenandhalfpercentNotesdue2031Member 2026-07-01 2026-07-0

Original reporting
Published Jul 1, 2026, 12:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 12:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CICB
Neutral
medium confidence
Mentioned
$CICB
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CICBNeutralLow
01

Why it matters

The only concrete new information in the text is the scheduled reporting date (Aug. 6, 2026, before market open) and call time (11 a.m. ET). No earnings numbers, guidance, or balance-sheet changes are disclosed in the excerpt.

02

Market read

Primarily a calendar/timing update for CICB into the Aug. 6 earnings event; no new fundamentals are provided here.

03

What to watch

If the attached Exhibit 99.1 contains additional specifics beyond the excerpt (e.g., preliminary results or notable commentary), that could raise actionability; this brief only reflects the provided text.

Relevance 7/10Novelty 3/10Timing: ahead of the Aug. 6, 2026 pre-market earnings release and 11 a.m. ET call

Background

The article is an SEC Form 8-K (Item 2.02 / Item 7.01) from CION Investment Corporation announcing the timing for its Q2 2026 results and related earnings call.

Company-level read

Ticker impact

$CICBNeutralMedium confidence
Context

CION Investment Corp filed an 8-K saying it will report Q2 results on Aug. 6, 2026 before the open and host a call at 11 a.m. ET.

Expected impact

Likely limited immediate impact; modest volatility risk increases as Aug. 6 approaches.

Evidence & confidence

The filing provides the earnings release date/time and conference call time, with no financial figures or guidance changes included in the excerpt.

Market effects

Minimal; this is company-specific scheduling for a business development/credit-style REIT/BDC structure, with no sector-wide datapoints.

Minimal; US-listed issuer timing disclosure only.

Minimal; no cross-border deal, regulation, or macro shock described.

Counterpoint

Traders may treat the date/time as already known from other calendars; without new financial content, the incremental edge is small.

Key entities

  • CION Investment Corporation

    US-listed company (CICB) filing an 8-K to announce Q2 results timing and an earnings conference call.

  • CION 7.50% Notes due 2029

    Listed trading symbol CICB on NYSE per the filing cover page; timing disclosure may affect credit sentiment around earnings.

  • CION 7.50% Notes due 2031

    Listed trading symbol CICC on NYSE per the filing cover page; timing disclosure may affect credit sentiment around earnings.

Related articles

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.